3
Objective: To determine the perception of possible infection caused by the severe acute respiratory syndrome coronavirus (SARS-CoV-2) and associated complications according to the labor sector in Peru. Methods: We performed an observational, cross sectional, and secondary data analysis. The study had three dependent variables that were obtained from a locally validated questionnaire, in which it is asked whether the professionals had the perception that they could be infected with SARS-CoV-2 at work, or could transmit the virus to their family/friends, and regarding the possibility of complications related to the infection. Results: Of the 2843 workers participating in the study, those in the health sector perceived that they were more likely to be infected at work. In the multivariate analysis, adjusted for four variables, health sector workers also perceived that they could be infected more frequently at work (adjusted prevalence ratio (aPR): 1.74; 95% confidence interval (CI): 1.40-2.15; p <0.001). These professionals, moreover, perceived that they could transmit the virus to their family/friends (aPR: 0.76; 95% CI: 0.63-0.92; p = 0.005) or that there would be complications resulting from the infection (aPR: 0.59; 95% CI: 0.48-0.73; p <0.001). On the other hand, engineering sector workers were the ones who had a greater perception that they could infect their family/friends (aPR: 1.95; 95% CI: 1.20-3.20; p = 0.007), while workers from other sectors perceived that they could have more chances of complications from the infection (aPR: 1.17; 95% CI: 1.05-1.30; p = 0.006). Conclusion: The health sector may be the most vulnerable in this context, which is why occupational health teams should develop and implement specific surveillance plans to prevent and reduce the number of coronavirus disease 2019 (COVID-19) cases among healthcare workers.
Loading PDF
15Transmission of infection from non-isolated patients with COVID-19 to healthcare workers
Transmission of infection from non-isolated patients with COVID-19 to healthcare workers
17Electrocardiographic features of patients with COVID-19: One year of unexpected manifestations
Electrocardiographic features of patients with COVID-19: One year of unexpected manifestations
20Active implications for dermatologists in 'SARS-CoV-2 ERA': Personal experience and review of literature.
Linked articles: COVID‐19 SPECIAL FORUM. J Eur Acad Dermatol Venereol 2020; 34: e346–e380.
86Use of SARS-CoV-2-infected deceased organ donors: Should we always "just say no?"
Use of SARS-CoV-2-infected deceased organ donors: Should we always "just say no?"
2Risk and severity of SARS-CoV-2 infection in breast cancer patients undergoing a structured infection screening program at the University and Hospital Trust of Verona
Risk and severity of SARS-CoV-2 infection in breast cancer patients undergoing a structured infection screening program at the University and Hospital Trust of Verona
Read more12Risk Factors for Hospitalization in People With HIV and COVID-19.
Kamis, Kevin F. MPH; Barbera, Lauren MD(c); Abdo, Mona PhD(c); Rowan, Sarah E. MD; Hussain, Cory MD; Gardner, Edward M. MD; Johnson, Steven C. MD; MaWhinney, Samantha ScD; Davis, Amelia J. MD; Carlson, Jesse MPH(c); Kozacka, Katie A. MD; Erlandson, Kristine M. MD, MS Author Information
Read more16Why N95 Should Be the Standard for All COVID-19 Inpatient Care.
Guidelines differ in their guidance on the use of N95 respirators versus medical masks for frontline health care workers working with patients with COVID-19, particularly when aerosolized procedures are not involved. This article makes the case that the existing data are inconclusive regarding the comparative effectiveness of N95 versus medical masks and could be misinterpreted. The authors suggest a reevaluation of this evidence or acknowledgement of these deficiencies in the setting of guidelines.
Read more23Immune response to three doses of mRNA SARS-CoV-2 vaccines in CD19-targeted chimeric antigen receptor Tcell immunotherapy recipients.
Immune response to three doses of mRNA SARS-CoV-2 vaccines in CD19-targeted chimeric antigen receptor Tcell immunotherapy recipients.
Read more34COVID-19 in Kidney Transplantation: Outcomes, Immunosuppression Management, and Operational Challenges.
COVID-19 in Kidney Transplantation: Outcomes, Immunosuppression Management, and Operational Challenges.
54SARS-CoV-2 routes of transmission and recommendations for preventing acquisition: joint British Infection Association (BIA), Healthcare Infection Society (HIS), Infection Prevention Society (IPS) and Royal College of Pathologists (RCPath) guidance
SARS-CoV-2 routes of transmission and recommendations for preventing acquisition: joint British Infection Association (BIA), Healthcare Infection Society (HIS), Infection Prevention Society (IPS) and Royal College of Pathologists (RCPath) guidance
Read more13Multisystem inflammatory syndrome in children associated with SARS-CoV-2 in a solid organ transplant recipient.
Multisystem inflammatory syndrome in children associated with SARS-CoV-2 in a solid organ transplant recipient.
7The intersection of genetics and COVID-19 in 2021: preview of the 2021 Rodney Howell Symposium
The intersection of genetics and COVID-19 in 2021: preview of the 2021 Rodney Howell Symposium
11COVID-19 and Gastrointestinal Tract Symptoms: Recognition, Containment, and Learning From the Past
COVID-19 and Gastrointestinal Tract Symptoms: Recognition, Containment, and Learning From the Past
23Guidance for the management of adult patients with coronavirus disease 2019.
In December 2019, a novel coronavirus was identified in Wuhan City, Hubei Province, China and later the disease was named coronavirus disease 2019 (COVID-19). On March 11, 2020, the World Health Organization (WHO) officially announced that COVID-19 had reached global pandemic status. This article summarized the understanding of the etiology, pathogenesis, epidemiology, clinical characteristics, diagnosis, treatment, rehabilitation, and prevention and control measures of COVID-19 based on the available data and anti-epidemic experience in China.
Read more8Rear Window—What Can the Gut Tell Us About Long-COVID?
Rear Window—What Can the Gut Tell Us About Long-COVID?
Copyright 2026 Cactus Communications. All rights reserved.
